Clinical Trial Update: FR901228 in Treating Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating FR901228 in metastatic breast cancer (Stage IV), including male and recurrent breast cancer cases, has completed enrollment and is spon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FR901228 (romidepsin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Male Breast Cancer, Recurrent Breast Cancer | Phase 2 | Status: COMPLETED